Banco Santander S.A. Sells 19,174 Shares of SPDR S&P Biotech ETF $XBI

Banco Santander S.A. trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 87.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,701 shares of the exchange traded fund’s stock after selling 19,174 shares during the period. Banco Santander S.A.’s holdings in SPDR S&P Biotech ETF were worth $271,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Compass Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $1,167,000. China Universal Asset Management Co. Ltd. raised its position in shares of SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $417,000. Altfest L J & Co. Inc. boosted its position in shares of SPDR S&P Biotech ETF by 63.1% in the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after purchasing an additional 48,326 shares during the last quarter. Finally, Brian Low Financial Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $668,000.

SPDR S&P Biotech ETF Trading Down 0.2%

NYSEARCA XBI opened at $127.37 on Monday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The stock has a 50-day simple moving average of $125.25 and a 200 day simple moving average of $112.88. The company has a market capitalization of $8.51 billion, a PE ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.